Significant Judgments News Today

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...

Interim condensed consolidated statement of operations ...

PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in... | May 16, 2023

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes... | May 9, 2023

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes to... | May 2, 2023

You should read the following discussion and analysis of our financial condition and plan of operations together with and our accompanying financial statements and the related notes appearing... | March 31, 2023

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes included elsewhere in this... | March 28, 2023

The following discussion and analysis of the financial condition and results of operations of GreenLight Biosciences Holdings PBC and its consolidated subsidiaries should be read together with the... | March 28, 2023

The following discussion contains managements discussion and analysis of our financial condition and results of operations and should be read together with the historical consolidated financial... | March 24, 2023

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes to those... | March 23, 2023